Last verified · v1.0
Calculator · health
Fractional Excretion Of Urea (Fe Urea) Calculator
Calculate FeUrea from spot urine and serum urea nitrogen and creatinine values. Differentiates pre-renal AKI from ATN — reliable even in patients on diuretic therapy.
Inputs
Fractional Excretion of Urea
—
Explain my result
Get a plain-English breakdown of your result with practical next steps.
The formula
How the
result is
computed.
What Is the Fractional Excretion of Urea (FEUrea)?
The Fractional Excretion of Urea (FEUrea), calculated with a feurea calculator, is a clinical biomarker that differentiates pre-renal acute kidney injury (AKI) from intrinsic renal causes such as acute tubular necrosis (ATN). Unlike the traditional Fractional Excretion of Sodium (FENa), the FeUrea remains diagnostically valid even when patients are actively receiving diuretic therapy — a common clinical scenario that renders FENa measurements unreliable and potentially misleading.
The FeUrea Formula Explained
The FeUrea is calculated using the following validated formula:
FEUrea (%) = (Urine Urea Nitrogen × Serum Creatinine) ÷ (Serum Urea Nitrogen × Urine Creatinine) × 100
Each variable contributes a specific physiologic signal to the calculation:
- Urine Urea Nitrogen (UUrea): Urea nitrogen concentration from a spot urine sample, expressed in mg/dL. Higher values indicate reduced tubular reabsorption of urea.
- Serum Urea Nitrogen / BUN (SUrea): Blood urea nitrogen drawn from a serum or plasma sample, in mg/dL. A disproportionately elevated BUN relative to creatinine may independently suggest volume depletion.
- Urine Creatinine (UCr): Creatinine measured in the spot urine sample, in mg/dL. Serves as a reference to normalize urea excretion relative to glomerular filtration.
- Serum Creatinine (SCr): Serum creatinine level in mg/dL. Paired with urine creatinine, it establishes the fractional clearance of urea relative to creatinine clearance.
Physiologic Derivation of the Formula
The FeUrea is derived from the clearance-ratio principle. Creatinine is freely filtered at the glomerulus and undergoes minimal tubular reabsorption, making it a reliable surrogate for GFR. By expressing urea clearance as a fraction of creatinine clearance, urine volume cancels from both the numerator and denominator — eliminating the need for a timed 24-hour urine collection. The resulting percentage represents what fraction of glomerular-filtered urea ultimately appears in the final excreted urine.
In pre-renal AKI, decreased renal perfusion triggers upregulation of tubular urea and sodium reabsorption, yielding a low FeUrea. When tubular epithelial cells sustain ischemic or nephrotoxic injury (intrinsic AKI / ATN), this reabsorptive capacity is lost, and a disproportionately large fraction of filtered urea escapes into urine.
Clinical Interpretation Thresholds
According to Carvounis et al., indexed in PubMed Central (PMC6033653), the validated FeUrea diagnostic thresholds in AKI are:
- FeUrea < 35%: Consistent with pre-renal AKI. The kidneys are actively conserving urea, reflecting intact tubular function responding appropriately to decreased perfusion pressure.
- FeUrea > 35%: Consistent with intrinsic renal AKI (ATN). Tubular injury prevents effective urea reabsorption, and a larger fraction escapes into the final urine.
The original study reported a sensitivity of approximately 85% and specificity of 92% for the 35% cutoff when distinguishing pre-renal from intrinsic AKI. Some institutions apply a 50% threshold in select populations; the appropriate cutoff depends on clinical context and institutional validation.
When to Use the FeUrea Calculator Instead of FENa
The FeUrea calculator is the preferred diagnostic tool whenever patients have received loop diuretics (furosemide, bumetanide, torsemide) or thiazide diuretics within the preceding 24 hours. Diuretics force renal sodium excretion, artificially elevating FENa to levels that falsely suggest ATN even in the presence of true volume depletion. Urea reabsorption occurs primarily in the proximal tubule and medullary collecting duct via urea transporters, pathways far less sensitive to loop diuretic interference — preserving the diagnostic value of FeUrea in this common clinical scenario.
Per the Loyola University Internal Medicine AKI Faculty Guide (2021), FeUrea is the recommended first-line test whenever recent diuretic exposure may have confounded sodium excretion data, making FENa interpretation unreliable.
Worked Clinical Example
Consider a 68-year-old patient admitted with oliguria following three days of profuse vomiting. The patient received furosemide 40 mg intravenously two hours before specimen collection. Laboratory values returned:
- Urine Urea Nitrogen: 280 mg/dL
- Serum Urea Nitrogen (BUN): 40 mg/dL
- Urine Creatinine: 120 mg/dL
- Serum Creatinine: 2.2 mg/dL
FeUrea = (280 × 2.2) ÷ (40 × 120) × 100 = 616 ÷ 4,800 × 100 = 12.8%
At 12.8% — well below the 35% cutoff — this result strongly supports pre-renal AKI from volume depletion. Aggressive isotonic intravenous fluid resuscitation is the appropriate first-line response, with renal function reassessment at 24 to 48 hours.
Limitations and Clinical Caveats
No single biomarker definitively establishes AKI etiology. The FeUrea calculator must always be interpreted within the full clinical context, including urine microscopy findings, hemodynamic assessment, medication history, and response to a fluid challenge. Conditions that may produce misleading FeUrea values include:
- Contrast-induced nephropathy: Early phases may display FeUrea < 35% despite nascent tubular injury due to intense vasospasm-driven urea reabsorption.
- Rhabdomyolysis: Myoglobin competes with creatinine in tubular secretion, distorting the urea-to-creatinine clearance ratio.
- Hepatorenal syndrome: Avid proximal tubular urea reabsorption driven by systemic vasodilation may mask coexisting intrinsic tubular dysfunction.
- Gastrointestinal bleeding or high-protein catabolism: Elevates BUN disproportionately to GFR, potentially underestimating the calculated FeUrea percentage.
Nephrology consultation is advisable for any AKI unresponsive to initial fluid management or when the FeUrea result conflicts with the clinical presentation.
Reference